NDC codes

FDA NDC Directory
Product NDC (as listed)0781-2354Labeler and product segments. Claims need a package NDC.
Product NDC at billing width00781-2354Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
0781-2354-27007812354270078123542721 CAPSULE in 1 BOTTLE (0781-2354-27)Marketed from Sep 1, 2026

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Pomalidomide
Generic name (nonproprietary)
pomalidomide
Active ingredients
Pomalidomide — 1 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Sandoz IncNDC labeler code 0781
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 220741
Marketing start
Listing expires
Identifiers
Product ID 0781-2354_4fcd4978-b2d1-4d1a-b239-717cddb8be1fSPL ID 4fcd4978-b2d1-4d1a-b239-717cddb8be1fSPL set ID 4fcd4978-b2d1-4d1a-b239-717cddb8be1fRxCUI 1369718, 1369726, 1369730, 1369734UNII D2UX06XLB5
Pharmacologic class
Thalidomide Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400781235427 followed by a unit qualifier and the quantity

Package 00781-2354-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

Pomalidomide capsules are a thalidomide analogue indicated for the treatment of adult patients: • in combination with dexamethasone, for patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last therapy ( 1.1 ). 1.1 Multiple Myeloma Pomalidomide capsules, in combination with dexamethasone, is indicated for adult patients with multiple myeloma (MM) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or within 60 days of completion of the last …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 0781-2354

What is NDC 0781-2354?
0781-2354 is the product NDC for Pomalidomide, Pomalidomide 1 mg/1 capsule, listed with the FDA by Sandoz Inc. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Pomalidomide.
What is the active ingredient?
Pomalidomide.
Who is the labeler?
Sandoz Inc, NDC labeler code 0781. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Pomalidomide?
42 other product NDCs are listed under this name. See all Pomalidomide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Pomalidomide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
pomalidomidePomalidomide 2 mg/1CapsuleOralNovadoz Pharmaceuticals LLC72205-17772205-0177-2172205-0177-91
pomalidomidePomalidomide 3 mg/1CapsuleOralNovadoz Pharmaceuticals LLC72205-17872205-0178-2172205-0178-91
pomalidomidePomalidomide 4 mg/1CapsuleOralNovadoz Pharmaceuticals LLC72205-17972205-0179-2172205-0179-91
PomalidomidePomalidomide 2 mg/1CapsuleOralSandoz Inc0781-235800781-2358-27
PomalidomidePomalidomide 3 mg/1CapsuleOralSandoz Inc0781-236600781-2366-27
PomalidomidePomalidomide 4 mg/1CapsuleOralSandoz Inc0781-236900781-2369-27
pomalidomidePomalidomide 4 mg/1CapsuleOralDr. Reddy's Laboratories Inc.43598-51743598-0517-0143598-0517-21
pomalidomidePomalidomide 3 mg/1CapsuleOralDr. Reddy's Laboratories Inc.43598-51843598-0518-0143598-0518-21
pomalidomidePomalidomide 2 mg/1CapsuleOralDr. Reddy's Laboratories Inc.43598-51943598-0519-0143598-0519-21
pomalidomidePomalidomide 1 mg/1CapsuleOralDr. Reddy's Laboratories Inc.43598-52043598-0520-0143598-0520-21

All 43 Pomalidomide NDCs

Other NDCs under ANDA 220741

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 220741
ProductStrengthForm · routeLabelerProduct NDC
PomalidomidePomalidomide 2 mg/1CapsuleOralSandoz Inc0781-2358
PomalidomidePomalidomide 3 mg/1CapsuleOralSandoz Inc0781-2366
PomalidomidePomalidomide 4 mg/1CapsuleOralSandoz Inc0781-2369

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in